Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - MADRIGAL PHARMACEUTICALS, INC. | d103755dex321.htm |
| EX-31.2 - EX-31.2 - MADRIGAL PHARMACEUTICALS, INC. | d103755dex312.htm |
| EX-31.1 - EX-31.1 - MADRIGAL PHARMACEUTICALS, INC. | d103755dex311.htm |
| EX-21.1 - EX-21.1 - MADRIGAL PHARMACEUTICALS, INC. | d103755dex211.htm |
| 10-K - 10-K - MADRIGAL PHARMACEUTICALS, INC. | d103755d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-225434, 333-219304) and Form S-8 (Nos. 333-141903, 333-152824, 333-173862, 333-181117, 333-187243, 333-194477, 333-202680, 333-206128, 333-212615, 333-224503 and 333-249866) of Madrigal Pharmaceuticals, Inc. of our report dated February 25, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
| /s/ PricewaterhouseCoopers LLP |
| Philadelphia, Pennsylvania |
| February 25, 2021 |